In 2026, we are focused on advancing our mission through science-driven innovation and purposeful development.
We are seeking victory in the fight against ovarian cancer.
#OvarianCancerResearch#EndOvarianCancer
Kaida BioPharma Co-Founder Dr. Stella Vnook shares her excitement to lead the Company into its clinical-stage transition, reaffirming her commitment to Kaida’s mission and long-term impact in women’s health.
https://t.co/wYPqXVuiME
#OvarianCancerResearch#EndOvarianCancer
Kaida BioPharma Founder and Board Member Craig Pierson highlighted the depth and breadth of Stella’s large-pharma and biotechnology experience, strategic insight, and global network as critical to Kaida’s continued progress.
https://t.co/wYPqXVuiME
#EndOvarianCancer
Ovarian cancer leaves too many patients with limited options and no lasting solutions.
At Kaida BioPharma, we’re committed to advancing new treatments to ensure there is #NoWomanLeftBehind in the fight against this disease.
At Kaida BioPharma, we are relentless in the fight against #OvarianCancer.
Our team is dedicated to advancing breakthrough treatments that have the potential to change the course of the disease and bring hope to the patients who need it most.
#EndOvarianCancer
We’re excited to be in San Francisco, CA from January 12-15 during the JP Morgan Healthcare Conference!
Reach out to [email protected] to schedule a meeting. We look forward to connecting!
#OvarianCancerResearch#EndOvarianCancer
Women’s health deserves attention every day of the year. At Kaida Biopharma, we remain committed to advancing better care, better options and better outcomes for women everywhere.
#NoWomanLeftBehind#EndOvarianCancer
At Kaida Biopharma, we’re driven to make a difference in the fight against #OvarianCancer.
Our team is focused on advancing breakthrough treatments that have the potential to change the course of this disease and bring hope to patients who need it most.
#OvarianCancerResearch
At Kaida Biopharma, our growing pipeline is focused on understanding the root causes of #OvarianCancer and developing innovative ways to overcome it.
Learn more about our research and trials: https://t.co/xg49vEWAJ5
#EndOvarianCancer#CancerResearch
#OvarianCancer is the second most common gynecologic cancer in the U.S. and the deadliest of all female reproductive cancers. This highlights the urgent need for greater awareness, research and more effective treatment options.
#NoWomanLeftBehind#OvarianCancerResearch
Stay connected with Kaida Biopharma! Sign up for email alerts to receive the latest news, updates and filings delivered straight to your inbox: https://t.co/gDRIbR46FY
#OvarianCancerResearch
Don’t miss Dr. Vnook, Co-Founder, presenting during the #DisruptTheBay2025 Pitch Competition on Thursday, November 13 at 12:06 PM ET in Tampa.
We will take the stage alongside innovators driving the future of Biotech, MedTech, and health innovation.
🔗: https://t.co/v280c4yJjN
We’re honored to be presenting at #DisrupttheBay2025 on November 8 in Tampa!
Disrupt the Bay, brings together leaders in health innovation to support children’s futures — from fighting pediatric cancer and food insecurity to advancing mental health.